Although transgenic α-synuclein mouse models exhibit diverse phenotypes, likely due to variations in methodologies, such as the location of the insertion site of the transgenes and promoter efficacy, most models closely recreate the neuropathological features of PD [253]. This evidence concerns the gene SNCA and Parkinson disease.